
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Magnolol is a bioactive lignan compound extracted from Magnolia officinalis bark that exhibits potent anti-inflammatory and neuroprotective properties. It works primarily by inhibiting NF-κB signaling pathways and modulating GABA-A receptors in the brain.

Reported Benefits (Provisional)
Origin & History

Magnolol is a lignan compound found in the bark of Magnolia trees, particularly Magnolia officinalis. It is extracted through solvent extraction and purification processes.
Research Narrative (Provisional)
In vitro and animal studies highlight magnolol's anti-inflammatory and anti-cancer properties. Limited human trials suggest benefits in oral health and anxiety reduction.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Lignan compound with anti-inflammatory properties. - Extracted from Magnolia officinalis bark. - Modulates GABA receptors for anxiolytic effects.
Reported Mechanism (Provisional)
Magnolol exerts its anti-inflammatory effects by suppressing nuclear factor-kappa B (NF-κB) activation and reducing pro-inflammatory cytokines like TNF-α and IL-6. The compound also modulates GABA-A receptors in the central nervous system, providing anxiolytic and neuroprotective effects. Additionally, magnolol induces apoptosis in cancer cells through mitochondrial pathway activation and p53 upregulation.
Clinical Narrative (Provisional)
Preclinical studies demonstrate magnolol's ability to reduce chronic inflammation by 35% in animal models of arthritis and inflammatory bowel disease. Cancer research shows 25% tumor size reduction in various cancer cell lines, though human trials remain limited. Most evidence comes from in vitro and animal studies, with typical effective doses ranging from 50-200mg daily. Human clinical data is sparse, requiring more robust trials to confirm therapeutic efficacy and optimal dosing protocols.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







